Langdon L. Miller serves as Executive at CLEVELAND BIOLABS INC, where they oversee executive responsibilities. Since joining the company, Langdon L. Miller has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 22, 2021 involved exercising options for 10,000 shares valued at $30.0K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 22, 2021 | CBLI | $30.0K | Option Exercise | 10,000 | $3.00 | Discretionary |
Langdon L. Miller currently holds 10,000 shares of CLEVELAND BIOLABS INC (CBLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Langdon L. Miller has been a net neutral trader of CBLI stock. They have purchased $0 and sold $0 worth of shares.
Langdon L. Miller's most recent insider trade was on Jul 22, 2021, when they sold 10,000 shares at $3.00 per share.
Get notified when new Form 4 filings are submitted